Rationale for the use of drugs in the treatment of cardiovascular disease - 2. Vasodilators
Journal Article
Boswood, A. Rationale for the use of drugs in the treatment of cardiovascular disease - 2. Vasodilators. In Practice, 20(2), 55-+
All Outputs (91)
Rationale for the use of drugs in the treatment of cardiovascular disease - 3. Positive inotropes
Journal Article
Boswood, A. Rationale for the use of drugs in the treatment of cardiovascular disease - 3. Positive inotropes. In Practice, 21(5), 253-+
Aortic and iliac thrombosis in six dogs
Journal Article
Boswood, A., Lamb, C., & White, R. Aortic and iliac thrombosis in six dogs. Journal of Small Animal Practice, 41(3), 109-114. https://doi.org/10.1111/j.1748-5827.2000.tb03176.x
Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs
Journal Article
Lamb, C. R., Wikeley, H., Boswood, A., & Pfeiffer, D. U. Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs. Veterinary Record, 148(23), 707-711. https://doi.org/10.1136/vr.148.23.707
Assessment of survey radiography as a method for diagnosis of congenital cardiac disease in dogs
Journal Article
Lamb, C. R., Boswood, A., Volkman, A., & Connolly, D. J. Assessment of survey radiography as a method for diagnosis of congenital cardiac disease in dogs. Journal of Small Animal Practice, 42(11), 541-545. https://doi.org/10.1111/j.1748-5827.2001.tb06024.x
Mitral valve disease study
Journal Article
Mattin, M. J., Boswood, A., Church, D. B., & Brodbelt, D. C. Mitral valve disease study. Veterinary Record, 173(21), https://doi.org/10.1136/vr.f7075
Incidence of elevation of cardiac troponin I prior to and following routine general anaesthesia in dogs
Journal Article
Cilli, F., Alibhai, H. I. K., Armitage-Chan, E., Boswood, A., Hammond, R. A., Jasani, S., & Brodbelt, D. C. Incidence of elevation of cardiac troponin I prior to and following routine general anaesthesia in dogs. Veterinary Anaesthesia and Analgesia, 37(5), 409-416. https://doi.org/10.1111/j.1467-2995.2010.00554.x
Current Use of Pimobendan in Canine Patients with Heart Disease
Journal Article
Boswood, A. Current Use of Pimobendan in Canine Patients with Heart Disease. https://doi.org/10.1016/j.cvsm.2010.04.003
ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP) AND VENTRICULAR REMODELLING IN DOGS WITH MITRAL VALVE DISEASE
Presentation / Conference Contribution
Hezzell, M. J., Boswood, A., & Elliott, J. ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP) AND VENTRICULAR REMODELLING IN DOGS WITH MITRAL VALVE DISEASE
Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease
Journal Article
Boswood, A., Smith, S., & Patteson, M. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease. Veterinary Record, 168(8), 222-222. https://doi.org/10.1136/vr.d1217
Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study).
Journal Article
Summerfield, N. J., Boswood, A., O'Grady, M. R., Gordon, S. G., Dukes-McEwan, J., Oyama, M. A., Smith, S., Patteson, M., French, A. T., Culshaw, G. J., Braz-Ruivo, L., Estrada, A., O'Sullivan, M. L., Loureiro, J., Willis, R., & Watson, P. Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study). Journal of Veterinary Internal Medicine, 26(6), 1337-49. https://doi.org/10.1111/j.1939-1676.2012.01026.x
Ultrasonographic measurement of flow-mediated vasodilation in dogs with chronic valvular disease.
Journal Article
Jones, I. D., Fuentes, V. L., Boswood, A., Hezzell, M. J., Wrigglesworth, D., Mateus, A. L. P., Moonarmart, W., & Elliott, J. Ultrasonographic measurement of flow-mediated vasodilation in dogs with chronic valvular disease. Journal of Veterinary Cardiology, 14(1), 203-10. https://doi.org/10.1016/j.jvc.2011.09.004
ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP), FIBROSIS AND ECHOCARDIOGRAPHIC INDICES IN DOGS WITH MITRAL VALVE DISEASE
Presentation / Conference Contribution
Hezzell, M. J., Falk, T., Olsen, L. H., Boswood, A., & Elliott, J. ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP), FIBROSIS AND ECHOCARDIOGRAPHIC INDICES IN DOGS WITH MITRAL VALVE DISEASE
Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease
Journal Article
Hezzell, M. J., Boswood, A., Moonarmart, W., & Elliott, J. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease. Journal of Veterinary Cardiology, 14(1), 269-79. https://doi.org/10.1016/j.jvc.2012.01.009
The Combined Prognostic Potential of Serum High-Sensitivity Cardiac Troponin I and N-Terminal pro-B-Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease.
Journal Article
Hezzell, M. J., Boswood, A., Chang, Y. M., Moonarmart, W., Souttar, K., & Elliott, J. The Combined Prognostic Potential of Serum High-Sensitivity Cardiac Troponin I and N-Terminal pro-B-Type Natriuretic Peptide Concentrations in Dogs with Degenerative Mitral Valve Disease. Journal of Veterinary Internal Medicine, 26(2), 302-311. https://doi.org/10.1111/j.1939-1676.2012.00894.x
Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease
Journal Article
Hezzell, M. J., Boswood, A., Chang, Y. M., Moonarmart, W., & Elliott, J. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease. American Journal of Veterinary Research, 73(11), 1765-74
Efficacy of Pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (The PROTECT Study)
Journal Article
Summerfield, N. J., Boswood, A., O'Grady, M. R., Gordon, S. G., Dukes-McEwan, J., Oyama, M. A., Smith, S., Patteson, M., French, A. T., Culshaw, G. J., Braz-Ruivo, L., Estrada, A., O'Sullivan, M. L., Loureiro, J., Willis, R., & Watson, P. Efficacy of Pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (The PROTECT Study). Kleintierpraxis, 58(4), 169-+. https://doi.org/10.1111/j.1939-1676.2012.01026.x
Prognostic Indicators in Cats with Hypertrophic Cardiomyopathy
Journal Article
Payne, J. R., Borgeat, K. A., Connolly, D. J., Boswood, A., Dennis, S., Wagner, T., Menaut, P., Maerz, I., Evans, D., Simons, V. E., Brodbelt, D. C., & Fuentes, V. L. Prognostic Indicators in Cats with Hypertrophic Cardiomyopathy. Journal of Veterinary Internal Medicine, 27(6), 1427-1436. https://doi.org/10.1111/jvim.12215
Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease
Journal Article
Oyama, M. A., Boswood, A., Connolly, D. J., Ettinger, S. J., Fox, P. R., Gordon, S. G., Rush, J. E., Sisson, D. D., Stepien, R. L., Wess, G., & Zannad, F. Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease. Journal of the American Veterinary Medical Association, 243(1), 71-82
Rationale for the use of drugs in the treatment of cardiovascular disease 4. Antiarrhythmic drugs
Journal Article
Boswood, A. Rationale for the use of drugs in the treatment of cardiovascular disease 4. Antiarrhythmic drugs. In Practice, 23(2), 63+